wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30277635-2BCFD774-D96E-4ED0-9334-57C1724506ED
Q30277635-2BCFD774-D96E-4ED0-9334-57C1724506ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30277635-2BCFD774-D96E-4ED0-9334-57C1724506ED
T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.
P2860
Q30277635-2BCFD774-D96E-4ED0-9334-57C1724506ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30277635-2BCFD774-D96E-4ED0-9334-57C1724506ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c81bc7b936fd1276ed5b668c18f3f7e04f96716c
P2860
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.